找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Resistant Hypertension in Chronic Kidney Disease; Adrian Covic,Mehmet Kanbay,Edgar V. Lerma Book 2017 Springer International Publishing AG

[復(fù)制鏈接]
樓主: energy
11#
發(fā)表于 2025-3-23 10:15:59 | 只看該作者
Definition and Characteristics of Hypertension Associated with Chronic Kidney Disease: EpidemiologiCKD than in general population, and its frequency increases progressively with the severity of CKD varying in different CKD causes including renal artery stenosis (93%), diabetic nephropathy (87%), and polycystic kidney disease (74%). The pathogenesis of hypertension associated with chronic kidney d
12#
發(fā)表于 2025-3-23 15:11:51 | 只看該作者
13#
發(fā)表于 2025-3-23 19:38:31 | 只看該作者
14#
發(fā)表于 2025-3-24 01:56:13 | 只看該作者
15#
發(fā)表于 2025-3-24 02:35:33 | 只看該作者
Risk Stratification of Resistant Hypertension in Chronic Kidney Disease, pressure on optimal doses of three or more antihypertensive agents, ideally one being a diuretic. It causes cardiovascular and renal complications. RHTN may be a part of chronic kidney disease (CKD). RHTN diagnosis should be made early and treatment should be effective. Because it is a significant
16#
發(fā)表于 2025-3-24 07:35:08 | 只看該作者
17#
發(fā)表于 2025-3-24 14:09:48 | 只看該作者
Pathophysiological Insights of Hypertension in Patients with Chronic Kidney Disease,t organ for hypertension-induced damage. The association between hypertension and chronic kidney disease (CKD) is well known. The prevalence of hypertension increases and control of hypertension becomes more difficult as kidney functions decline. Understanding of the pathophysiology of hypertension
18#
發(fā)表于 2025-3-24 17:11:32 | 只看該作者
Secondary Causes: Work-Up and Its Specificities in CKD: Influence of Arterial Stiffening,ong time. Increased arterial stiffness is a major nontraditional cardiovascular risk factor in CKD reflecting the difficulty of the large arteries to convert flow oscillations into continuous blood flow due to significant morphological changes induced by this pathological condition. Surrogate marker
19#
發(fā)表于 2025-3-24 21:00:25 | 只看該作者
20#
發(fā)表于 2025-3-25 01:20:18 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-12 18:10
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
横山县| 科技| 永城市| 沛县| 四会市| 高雄市| 安远县| 武胜县| 平果县| 赣榆县| 杭锦旗| 曲沃县| 疏勒县| 鹤山市| 吉林省| 墨玉县| 六盘水市| 都昌县| 富锦市| 信阳市| 河间市| 城步| 九龙县| 虎林市| 安龙县| 阿尔山市| 土默特右旗| 晋江市| 旺苍县| 原阳县| 乐东| 伊川县| 墨江| 会理县| 兴和县| 安仁县| 酒泉市| 明溪县| 清远市| 兴海县| 平谷区|